ArticleArthritis research & therapy2026
Defining pain trajectories in juvenile arthritis and associated patient characteristics.
Article in Arthritis research & therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundJuvenile idiopathic arthritis (JIA) impacts up to 400 per 100,000 children, with a substantial number experiencing chronic pain. Despite its prevalence, research and treatment targeting chronic pain in JIA are limited. This study aims to model pain scores as latent pain trajectories (LPT) and explore the association between LPT and clinical and biological characteristics of patients.
methodsData collected from the Electronic Health Records (EHR) included patient characteristics (e.g. age and biological sex), disease activity measures such as Active Joint Count (AJC) and Physician Global Assessment (PhGA), and patient reported outcomes (e.g. pain and well-being) of 233 patients. Blood plasma samples of 24 patients, acquired during routine care, were analyzed using Nulisa (120-plex Central Nervous System Disease Panel by Alamar) to quantify 127 protein concentrations. Follow-up was conducted in accordance with standard medical care, being every three months.
resultsThe analysis included 233 patients, revealing a model with three distinct trajectories as most representative. Baseline disease activity, indicated by AJC and PhGA, did not significantly differ between trajectories (p = 0.4, p = 0.6, respectively). However, baseline Patient/Parent Global Assessment (PPGA) scores were significantly lower in the mild trajectory compared to moderate and chronic trajectories (p < 0.001). In an exploratory analysis of blood plasma samples of 24 patients 9 proteins (Aβ-40, GFAP, IGFBP7, IL-12p70, IL-2, IL-5, NPY, TREM2, UBB) differed between trajectories at baseline, while at follow-up 11 proteins differed (IL-4, pTau-217, IGF1R, IL-6, pTau-231, SNAP25, CXCL8, GOT1, CCL2, BACE1, CST3). No overlap between proteins at these different timepoints was as observed between the protein sets at baseline and follow-up.
conclusionWe identified three latent pain trajectories differentiating JIA patients' pain course as mild resolving, moderate slowly resolving, or moderate chronic. Older age was significantly associated with moderate and chronic trajectories. We observed trajectory‑related patterns in circulating protein concentrations in a small subset of patients, which should be confirmed in larger, prospectively designed cohorts.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.